Manning Paul B Insider Trades

Insider Trading History

Track insider trading activity for Manning Paul B. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $40.6k 4,618 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.6k 4,618 shares
$4.90
$8.80
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $24.3M 2,763,527 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3M 550,458 shares
$5.45
$8.80
Liquidia
Liquidia LQDA
Director
Holding Value $0 0 shares
Last Trade
Feb 11, 2026 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$2.35M 55,116 shares
$42.63
$55.69
Liquidia
Liquidia LQDA
Director
Holding Value $26.2M 469,583 shares
Last Trade
Feb 11, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.35M 55,116 shares
$42.63
$55.69
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
10% owner
Holding Value $23.2M 3,958,189 shares
Last Trade
Nov 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24M 5,157,677 shares
$4.66
$5.87
Liquidia
Liquidia LQDA
Director
Holding Value $28.1M 505,058 shares
Last Trade
Sep 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.45M 328,268 shares
$28.78
$55.69
Liquidia
Liquidia LQDA
Director
Holding Value $42.3M 759,096 shares
Last Trade
Aug 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.2M 188,232 shares
$27.62
$55.69
Liquidia
Liquidia LQDA
Director
Holding Value $52.8M 947,328 shares
Last Trade
Aug 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.31M 154,337 shares
$27.94
$55.69
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $19.5M 2,213,069 shares
Last Trade
Jun 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5M 1,070,663 shares
$4.67
$8.80
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $125k 14,240 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.3k 14,240 shares
$4.94
$8.80
Liquidia
Liquidia LQDA
Director
Holding Value $2.16M 38,755 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 18,396 shares
$13.59
$55.69
Taysha Gene Therapies
Taysha Gene Therapies TSHA
10% owner
Holding Value $15.8M 2,841,704 shares
Last Trade
May 30, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.06M 750,000 shares
$2.75
$5.55
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $11.5M 1,303,752 shares
Last Trade
Dec 16, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.5M 1,250,000 shares
$6.00
$8.80
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
10% owner
Holding Value $152M 25,828,094 shares
Last Trade
Nov 26, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$500k 450,000 shares
$1.11
$5.87
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
10% owner
Holding Value $154M 26,278,094 shares
Last Trade
Nov 22, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$48.1M 45,842,696 shares
$1.05
$5.87
Verrica Pharmaceuticals
Verrica Pharmaceuticals VRCA
10% owner
Holding Value $0 0 shares
Last Trade
Sep 19, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$5.19M 2,675,611 shares
$1.94
$5.87
Liquidia
Liquidia LQDA
Director
Holding Value $45.5M 816,311 shares
Last Trade
Sep 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3M 337,078 shares
$8.90
$55.69
Taysha Gene Therapies
Taysha Gene Therapies TSHA
10% owner
Holding Value $7.4M 1,333,333 shares
Last Trade
Jun 27, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3M 1,333,333 shares
$2.25
$5.55
Candel Therapeutics
Candel Therapeutics CADL
Director
Holding Value $125k 14,240 shares
Last Trade
Jun 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$81.3k 14,240 shares
$5.71
$8.80
Liquidia
Liquidia LQDA
Director
Holding Value $16.7M 299,689 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$250k 20,359 shares
$12.28
$55.69

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up